Pacer Advisors, Inc. Ligand Pharmaceuticals Inc Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$49.57 - $72.63 $6 Million - $8.79 Million	121,049 Added 59.14%	325,727 $23.3 Million
Q3 2023 Nov 13, 2023	BUY	$58.86 - $72.67 $4 Million - $4.94 Million	67,928 Added 49.67%	204,678 $12.3 Million
Q2 2023 Jul 12, 2023	SELL	$69.53 - $79.33 $1.17 Million - $1.33 Million	-16,793 Reduced 10.94%	136,750 $9.86 Million
Q1 2023 May 02, 2023	BUY	$65.67 - $77.08 $2.72 Million - $3.19 Million	41,438 Added 36.96%	153,543 $11.3 Million
Q4 2022 Feb 06, 2023	BUY	$61.72 - $96.74 $6.92 Million - $10.8 Million	112,105 New	112,105 $7.49 Million
Q2 2022 Aug 12, 2022	BUY	$74.52 - $117.06 $4.34 Million - $6.81 Million	58,178 New	58,178 $5.19 Million
Q3 2021 Oct 15, 2021	SELL	$102.33 - $144.73 $179,486 - $253,856	-1,754 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$113.03 - $155.64 $56,175 - $77,353	-497 Reduced 22.08%	1,754 $230,000
Q1 2021 Apr 05, 2021	SELL	$99.52 - $215.83 $94,643 - $205,254	-951 Reduced 29.7%	2,251 $343,000
Q4 2020 Jan 20, 2021	SELL	$80.55 - $106.05 $127,832 - $168,301	-1,587 Reduced 33.14%	3,202 $318,000
Q3 2020 Oct 19, 2020	BUY	$89.56 - $126.72 $428,902 - $606,862	4,789 New	4,789 $456,000
Q1 2020 Apr 23, 2020	SELL	$63.37 - $107.88 $378,128 - $643,719	-5,967 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$96.94 - $113.59 $160,435 - $187,991	-1,655 Reduced 21.71%	5,967 $622,000
Q3 2019 Oct 10, 2019	SELL	$86.25 - $120.16 $50,628 - $70,533	-587 Reduced 7.15%	7,622 $759,000
Q2 2019 Aug 12, 2019	BUY	$107.38 - $129.34 $881,482 - $1.06 Million	8,209 New	8,209 $937,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $172,002 - $364,654	-1,340 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $282,981 - $367,816	1,340 New	1,340 $368,000
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $69,315 - $91,310	-500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $64,180 - $73,520	500	500 $68,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account